表紙
市場調査レポート

ギラン・バレー症候群:世界の治験レビュー

Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 307774
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
ギラン・バレー症候群:世界の治験レビュー Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014
出版日: 2014年06月30日 ページ情報: 英文 72 Pages
概要

当レポートでは、世界の主要地域おけるギラン・バレー症候群治療薬の治験数や被験者数、段階別の動向、主要企業や機関、治験のプロファイルなどをまとめています。

イントロダクション

  • ギラン・バレー症候群
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対するギラン・バレー症候群の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患の治験件数に対するギラン・バレー症候群の治験件数比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

ギラン・バレー症候群の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Harvard Pilgrim Health Care, Inc.
    • GlaxoSmithKline plc
    • CSL Limited
  • 代表的な研究機関・病院の治験の概要
    • Erasmus MC
    • FDA Office of Orphan Products Development
    • Chhatrapati Shahuji Maharaj Medical University
    • Mansoura University
    • University Medical Centre Ljubljana
    • University of Versailles
    • University of Cologne
    • NHS Greater Glasgow and Clyde
    • National Taiwan University Hospital

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2221CTIDB

GlobalData's clinical trial report, "Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Guillain-Barre Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Guillain-Barre Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Guillain-Barre Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Guillain-Barre Syndrome
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Guillain-Barre Syndrome
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Guillain-Barre Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Harvard Pilgrim Health Care, Inc.
      • Clinical Trial Overview of Harvard Pilgrim Health Care, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • FDA Office of Orphan Products Development
      • Clinical Trial Overview of FDA Office of Orphan Products Development
      • Chhatrapati Shahuji Maharaj Medical University
      • Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University
      • Mansoura University
      • Clinical Trial Overview of Mansoura University
      • University Medical Centre Ljubljana
      • Clinical Trial Overview of University Medical Centre Ljubljana
      • University of Versailles
      • Clinical Trial Overview of University of Versailles
      • University of Cologne
      • Clinical Trial Overview of University of Cologne
      • NHS Greater Glasgow and Clyde
      • Clinical Trial Overview of NHS Greater Glasgow and Clyde
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Region, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Guillain-Barre Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Guillain-Barre Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvard Pilgrim Health Care, Inc., 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chhatrapati Shahuji Maharaj Medical University, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mansoura University, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Centre Ljubljana, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Versailles, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*

List of Figures

  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Guillain-Barre Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Guillain-Barre Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top